The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer

医学 外科肿瘤学 乳腺癌 全身疗法 阶段(地层学) 肿瘤科 内科学 癌症 外科 生物 古生物学
作者
Eriko Tokunaga,Yumiko Koi,Wakako Tajiri,Chinami Koga,Hideki Ijichi,Sayuri Akiyoshi,Junji Kawasaki,Yoshiaki Nakamura,Kenichi Taguchi,Masahiro Okamoto
出处
期刊:Breast Cancer [Springer Science+Business Media]
卷期号:32 (2): 426-433 被引量:1
标识
DOI:10.1007/s12282-025-01675-w
摘要

BACKGROUND: Systemic therapy (ST) is essential for de novo stage IV breast cancer (BC). Stage IV BCs are highly heterogeneous, and it seems inappropriate to treat all de novo stage IV BCs equally. The survival benefit of surgery for primary sites in patients with de novo stage IV BC remains inconclusive. PATIENTS AND METHODS: We investigated 220 patients with clinical de novo stage IV BC. The relationship between primary site surgery and overall survival (OS) was analyzed. Factors such as tumor subtype, timing of surgery, and efficacy of ST were also evaluated. RESULTS: The median follow-up time was 37.9 (0.5-201.7) months. In the total cohort, the median OS of the patients with and without primary site surgery was 70.5 months (95% confidence interval [CI] 58.4-107.3) and 42.7 months (95% CI 35.7-48.8), respectively. The OS was significantly longer in patients who underwent primary site surgery, especially in the hormone receptor (HR) + /HER2- and HER2 + subtypes, but not in the triple-negative subtype. OS prolongation was significant in patients who underwent surgery ≥ 24 months after the first diagnosis and in whom the first-line ST was effective for ≥ 24 months. Primary site surgery was a good prognostic factor in both univariate and multivariate analyses. CONCLUSIONS: The OS was significantly longer in patients with de novo stage IV BC who underwent primary site surgery than in those who did not undergo surgery. Our results suggest that the tumor subtypes, efficacy of ST, and timing of surgery influenced the benefits of surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淘宝叮咚发布了新的文献求助10
1秒前
852的应助被369ninja采纳,获得10
1秒前
Nabi完成签到 ,获得积分10
2秒前
小马甲的应助被美羊羊采纳,获得10
2秒前
悲伤猫猫头完成签到,获得积分10
2秒前
5秒前
灵巧完成签到,获得积分10
7秒前
dundun完成签到,获得积分10
7秒前
小狗便利店完成签到,获得积分10
8秒前
orixero的应助被lwapple采纳,获得10
9秒前
NexusExplorer的应助被李飞采纳,获得10
10秒前
芋头233发布了新的文献求助10
11秒前
汉堡包的应助被独特长颈鹿采纳,获得10
12秒前
希望天下0贩的0的应助被369ninja采纳,获得10
12秒前
hh完成签到,获得积分10
14秒前
15秒前
15秒前
專注完美近乎苛求完成签到 ,获得积分0
15秒前
大个的应助被芋头233采纳,获得10
15秒前
16秒前
xxx完成签到 ,获得积分10
17秒前
充电宝的应助被369ninja采纳,获得10
17秒前
拼搏映菡发布了新的文献求助10
18秒前
18秒前
水波不兴完成签到 ,获得积分10
20秒前
Jasper的应助被过过过采纳,获得10
20秒前
20秒前
HR完成签到,获得积分10
21秒前
内向忆南完成签到,获得积分10
21秒前
贾文浩发布了新的文献求助10
21秒前
penicillin完成签到,获得积分10
21秒前
22秒前
李飞发布了新的文献求助10
23秒前
hhj完成签到,获得积分20
24秒前
3921337477发布了新的文献求助10
24秒前
26秒前
shirley发布了新的文献求助10
26秒前
27秒前
3921337477发布了新的文献求助10
27秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573478
关于积分的说明 21831914
捐赠科研通 7781737
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962